Search

6 results for “dyslipidemia”

• Molecules of MillenniumOpen Access

  Proprotein convertase subtilisin/kexin type 9 enzyme inhibitors: An emerging new therapeutic option for the treatment of dyslipidemia

  Faizan Mazhar, Nafis Haider

  Vol. 7 · Issue 4 · pp. 190–3

  https://doi.org/10.4103/0976-500X.195906
  Full text ↗PDF

• Original Research ArticleOpen Access

  Interrogating the Antiobesity Efficacy of Flacourtia inermis Roxb. Fruits in High Fat Diet-induced Obese Rats

  Bency Baby Thelappilly, R Murali, TNK Suriyaprakash, VV Venkatachalam, S. Vigil Anbiah, Srinivasan N, Suhail PT

  Vol. 16 · Issue 1 · pp. 46–57

  https://doi.org/10.1177/0976500X241292439
  Full text ↗PDF

• Case ReportOpen Access

  Delayed Extensive Local Reaction to the mRNA-1273 Vaccine against SARS-CoV-2: A Case Report

  Renato Ferreira-da-Silva, Inês Ribeiro-Vaz, Ana Marta Silva, Fernando Nunes, Manuela Morato, Jorge Junqueira Polónia, Paulo Guedes

  Vol. 13 · Issue 4 · pp. 401–403

  https://doi.org/10.1177/0976500X221147748
  Full text ↗PDF

• Research PaperOpen Access

  Is the peripheral arterial disease in low risk type 2 diabetic patients influenced by body mass index, lipidemic control, and statins?

  Jayesh Dalpatbhai Solanki, Amit H. Makwana, Hemant B. Mehta, Pradnya A. Gokhale, Chinmay J. Shah

  Vol. 7 · Issue 2 · pp. 87–92

  https://doi.org/10.4103/0976-500X.184772
  Full text ↗PDF

• Molecules of the MillenniumOpen Access

  Belatacept: A worthy alternative to cyclosporine?

  George Melvin, Selvarajan Sandhiya, Kumaresan Subraja

  Vol. 3 · Issue 1 · pp. 90–92

  https://doi.org/10.4103/0976-500X.92499
  Full text ↗PDF

• Research PaperOpen Access

  Association between altered thyroid state and insulin resistance

  Kunal B. Kapadia, Parloop A. Bhatt, Jigna S. Shah

  Vol. 3 · Issue 2 · pp. 156–160

  https://doi.org/10.4103/0976-500X.95517
  Full text ↗PDF